Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer

This study was performed to assess the efficacy and safety of docetaxel, cisplatin and fluorouracil combination in patients with unresectable locally advanced oesophageal squamous cell carcinoma. Treatment consisted of docetaxel 60 mg m(−2), cisplatin 75 mg m(−2) on day 1 and fluorouracil 750 mg m(−...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiarion-Sileni, V, Corti, L, Ruol, A, Innocente, R, Boso, C, Del Bianco, P, Pigozzo, J, Mazzarotto, R, Tomassi, O, Ancona, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360020/
https://www.ncbi.nlm.nih.gov/pubmed/17245338
http://dx.doi.org/10.1038/sj.bjc.6603585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360020/
https://www.ncbi.nlm.nih.gov/pubmed/17245338
http://dx.doi.org/10.1038/sj.bjc.6603585

Ejemplares similares